Literature DB >> 32125361

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma.

Marine Baron1, Lisa Belin2, Nathalie Cassoux3, Christine Fardeau4, Marion Blaizeau5, Carole Soussain6, Caroline Houillier7, Khê Hoang-Xuan7, Emmanuel Gyan8, Marie-Laure Le Lez9, Anne Lavaud1, Pierre Soubeyran10, Bahram Bodaghi4, Myrto Costopoulos11, Véronique Leblond1, Valérie Touitou4, Karim Maloum11, Marie-Hélène Errera12, Damien Roos-Weil1, Magali Le Garff-Tavernier11, Sylvain Choquet1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32125361     DOI: 10.1182/blood.2019003073

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma.

Authors:  Pui-Lun Yip; Ching-Pong Lam; Wai-Pan Lau; Tsan-Hei Luk; Sze-Man June Lau
Journal:  Ann Hematol       Date:  2020-09-25       Impact factor: 3.673

2.  Primary central nervous system lymphoma in older adults and the rationale for maintenance strategies: a narrative review.

Authors:  Mazie Tsang; James L Rubenstein; Elisa Jacobsen Pulczynski
Journal:  Ann Lymphoma       Date:  2021-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.